BioSpace News Archive

Volpara Solutions and ScreenPoint Medical BV announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics in the United States, Australia, New Zealand, and parts of Asia.

Valiant Recovery Inc. announced that in recognition of their 10th Anniversary, they are offering Two Free full 30 day Addiction Treatment Programs.

Lifestyle Delivery Systems Inc.,, announces 10 additional dispensaries as CSPA Group, Inc., the Company’s wholly-owned subsidiary, continues to expand the availability of its flagship product, CannaStrips™, within the California market.

NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that it has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of an industry outreach initiative to establish reliable domestic molybdenum-99 (Mo-99) production without the use of highly enriched uranium.

ThermoGenesis, a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL) and a market leader in automated cellular processing, today announced that CBR® (Cord Blood Registry), the country’s largest newborn stem cell storage bank has begun the process to transition to ThermoGenesis’ next-generation AXP® II System for the rapid processing of cord blood units

RSIP Vision, a global leader in artificial intelligence (AI), computer vision, and image processing technology, has announced the release of an advanced AI lung segmentation module that reduces the threat of false positives in biopsies

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2019 conference call on Wednesday, July 31, at 4 p.m. CT (5 p.m. ET).

DoctorLogic, the creators of the all-in-one Website Marketing Platform exclusively for healthcare providers, is proud to announce the launch of its newly redesigned website at https://www.doctorlogic.com.

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the second quarter ended June 30, 2019 after the market closes on Tuesday, August 6, 2019.

Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today the publication of a peer-reviewed paper demonstrating that Remote Electrical Neuromodulation (REN) is as effective as acute pharmacological treatments in treating the symptoms of migraine.